302 related articles for article (PubMed ID: 28802407)
1. Immunological characterization of latent tuberculosis infection in a low endemic country.
de Paus RA; van Meijgaarden KE; Prins C; Kamphorst MH; Arend SM; Ottenhoff THM; Joosten SA
Tuberculosis (Edinb); 2017 Sep; 106():62-72. PubMed ID: 28802407
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the QuantiFERON?-TB Gold In-Tube assay and tuberculin skin test for the diagnosis of Mycobacterium tuberculosis infection in northeastern Thailand.
Reechaipichitkul W; Pimrin W; Bourpoern J; Prompinij S; Faksri K
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):236-44. PubMed ID: 26342121
[TBL] [Abstract][Full Text] [Related]
3. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
[TBL] [Abstract][Full Text] [Related]
4. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.
Petruccioli E; Vanini V; Chiacchio T; Cuzzi G; Cirillo DM; Palmieri F; Ippolito G; Goletti D
Tuberculosis (Edinb); 2017 Sep; 106():38-43. PubMed ID: 28802403
[TBL] [Abstract][Full Text] [Related]
5. CD4
Borgström EW; Fröberg G; Correia-Neves M; Atterfelt FB; Bellbrant J; Szulkin R; Chryssanthou E; Ängeby K; Tecleab T; Ruhwald M; Andersen P; Källenius G; Bruchfeld J
Tuberculosis (Edinb); 2020 Jul; 123():101959. PubMed ID: 32741535
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
Harada N
Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
[TBL] [Abstract][Full Text] [Related]
7. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
[TBL] [Abstract][Full Text] [Related]
8. Close contact interferon-gamma response to the new PstS1
de Araujo LS; de Bárbara Moreira da Silva Lins N; Leung JA; Mello FC; Saad MH
BMC Res Notes; 2017 Jan; 10(1):59. PubMed ID: 28114976
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary responses to pathogen-specific antigens in latent Mycobacterium tuberculosis infection.
Jarvela JR; Tuscano L; Lee H; Silver RF
Tuberculosis (Edinb); 2016 Jan; 96():158-64. PubMed ID: 26732045
[TBL] [Abstract][Full Text] [Related]
10. Borderline QuantiFERON results and the distinction between specific responses and test variability.
Uzorka JW; Bossink AWJ; Franken WPJ; Thijsen SFT; Leyten EMS; van Haeften AC; Doornenbal G; Boonstra P; Ottenhoff THM; Arend SM
Tuberculosis (Edinb); 2018 Jul; 111():102-108. PubMed ID: 30029893
[TBL] [Abstract][Full Text] [Related]
11. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
Sun Q; Wei W; Sha W
PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
[TBL] [Abstract][Full Text] [Related]
12. Association of the level of IFN-γ produced by T cells in response to Mycobacterium tuberculosis-specific antigens with the size of skin test indurations among individuals with latent tuberculosis in a highly tuberculosis-endemic setting.
Legesse M; Ameni G; Mamo G; Medhin G; Bjune G; Abebe F
Int Immunol; 2012 Feb; 24(2):71-8. PubMed ID: 22298884
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
[TBL] [Abstract][Full Text] [Related]
14. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
15. A multicentre verification study of the QuantiFERON
Pieterman ED; Liqui Lung FG; Verbon A; Bax HI; Ang CW; Berkhout J; Blaauw G; Brandenburg A; van Burgel ND; Claessen A; van Dijk K; Heron M; Hooghiemstra M; Leussenkamp-Hummelink R; van Lochem E; van Loo IHM; Mulder B; Ott A; Pontesilli O; Reuwer A; Rombouts P; Saegeman V; Scholing M; Vainio S; de Steenwinkel JEM
Tuberculosis (Edinb); 2018 Jan; 108():136-142. PubMed ID: 29523314
[TBL] [Abstract][Full Text] [Related]
16. Profile of interferon-gamma response to latency-associated and novel in vivo expressed antigens in a cohort of subjects recently exposed to Mycobacterium tuberculosis.
Araujo LS; da Silva NBM; da Silva RJ; Leung JAM; Mello FCQ; Saad MHF
Tuberculosis (Edinb); 2015 Dec; 95(6):751-757. PubMed ID: 26421415
[TBL] [Abstract][Full Text] [Related]
17. Differential positive TSPOT assay responses to ESAT-6 and CFP-10 in health care workers.
Agarwal S; Nguyen DT; Lew JD; Teeter LD; Yamal JM; Restrepo BI; Brown EL; Dorman SE; Graviss EA
Tuberculosis (Edinb); 2016 Dec; 101S():S83-S91. PubMed ID: 27727133
[TBL] [Abstract][Full Text] [Related]
18. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.
Gupta D; Kumar S; Aggarwal AN; Verma I; Agarwal R
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):95-101. PubMed ID: 22117500
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
[TBL] [Abstract][Full Text] [Related]
20. Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents.
Klein M; Jarosová K; Forejtová S; Bečvář R; Sedová L; Pavelka K; Simková G; Svobodová R; Hviscová K; Mann H; Půtová I; Vencovský J
Clin Exp Rheumatol; 2013; 31(1):111-7. PubMed ID: 23101473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
